Exclusive patent, know-how, technology and trade secret license to use the 'Hemangeol' trademarks and trade names to offer, sell, import, exploit, commercialize, dispose of, make, have made and sublicense an oral pharmaceutical solution product containing propranolol as active pharmaceutical ingredient, including improvements, line extensions and modifications, to treat infantile hemangioma.